Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany by Bjoern Jensen, Nadine Luebke, Torsten Feldt, Verena Keitel, Timo Brandenburger, Detlef Kindgen-Milles, Matthias Lutterbeck, Noemi F Freise, David Schoeler, Rainer Haas, Alexander Dilthey, Ortwin Adams, Andreas Walker, Joerg Timm, Tom Luedde

Connect to this object online.